What Happened?
San Diego, CA-based Astute Medical appointed Chris Hibberd as Chief Executive Officer
About the Company
Astute Medical is committed to improving patient outcomes through the identification and validation of unique biomarkers. Our measurement methods help rapidly assess high-risk acute conditions and diseases. By incoporating useful clinical tools, we help healthcare professionals provide rapid, accurate and life-saving responses.
About the Person
Christopher R. Hibberd is the Co-Founder and Chief Executive Officer of Astute Medical Inc., a developer of biomarker-based diagnostics intended to help physicians rapidly identify and treat acute conditions for critically ill patients. Mr. Hibberd has more than 20 years experience as a leader in business strategy and corporate development. Prior to the founding of Astute Medical in 2007, Mr. Hibberd spent 10 years at Biosite Incorporated, a leading diagnostics company acquired by Inverness Medical Innovations for $1.7 billion. As Senior Vice-President of Corporate Development at Biosite, Mr. Hibberd was co-responsible for the identification and pursuit of strategic business opportunities, including technology acquisitions, partnerships and alliances.
Info Source
News
Short Profile